• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERVASCULAR SAS HEMAGARD KNITTED GRAFT; VASCULAR POLYESTER GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERVASCULAR SAS HEMAGARD KNITTED GRAFT; VASCULAR POLYESTER GRAFT Back to Search Results
Model Number HGKAX0808
Device Problem Manufacturing, Packaging or Shipping Problem (2975)
Patient Problem Blood Loss (2597)
Event Date 02/01/2018
Event Type  Injury  
Event Description
It was reported that during a vascular surgery, a problem was encountered with the permeability of a graft.After the doctor tunneled the graft inside the patient, the blood started diffused from the whole sides of the graft so he removed it, he used another one.Also, he faced the same problem with the 2nd involved hemagard axillo-bifemoral graft but he managed it in his own way (see manufacturer report 1640201-2018-00011 for the first involved device).No additional information could be obtained at the date of this report.
 
Manufacturer Narrative
The event occurred in february 2018, however the exact event date is unknown.It was arbitrarily set to on (b)(6) 2018 in date of event and in implant date.The serial number of the concerned graft is unknown.However the lot number: 17e25 was provided allowing to identify 3 possible grafts for the reported event.(3331/213) a review of the complaint device history records indicated that the 3 possible grafts were processed and inspected according to established procedures and were therefore released following acceptable quality inspections and tests.Specifically, no anomaly was evidenced in the collagen coating records.The review of the water permeability testing records of products coated on the same day as the possible devices indicated values well within product specifications.(11/213) one retention sample coated on the same day and under the same conditions as the possible devices underwent water permeability testing.The test result indicated a value well within product specifications ( 5 ml/cm²/min).(4117) device is not accessible for testing as it remained implanted in patient.(4109/213) the review of post-marketing historical data indicated that no other similar complaint was reported for the same lot number.(67) the cause of the event remains unknown.However, the conducted investigation and testing performed would tend to indicate that the product was not defective at the time of manufacturing.(22) please note that blood leakage and seroma formation are foreseeable side-effects as indicated in the instructions for use.In addition, the case was submitted to the corporate medical officer for review, together with the first case concerning same patient and reported by same physician (mdr#: 1640201-2018-00011).His medical assessment is as follows: "the event describes the use of two grafts for a axillo-bifemoral surgical bypass.The first graft had a considerable amount of bleeding throughout the body of the graft when the anastomosis were completed and circulation was restored.The surgeon decided to replace the graft with another one.Before implant the physician decided to soak the graft in blood similarly to what was originally performed with non-coated graft several years ago.The graft was implanted in normal fashion and bleeding was noted when the circulation was reestablished although the amount was significantly less.The graft remained implanted and the procedure was completed.No further complications have been described in the complaint recorded.The first implanted graft was sent to a lab for macro and microscopic examination.The result of the analysis did not show any abnormality.There is no mention regarding the patient's pre-conditions.Usually patients in need of this kind of intervention are at a very late stage of the atherosclerotic disease and under significant blood thinning medications.Therefore it could be assumed the bleeding observed is mostly due to the existing coagulation parameters at the moment of the operation and not from a device lack of performances.".
 
Event Description
The doctor inserted the graft in saline and later in blood and left the graft for few minutes for percolating to occur and then he used the graft.At this stage less blood leakage happened but it took more than 10 minutes to stop leak.The drains post-surgery produced lots of fluids for 3-4 days (post-operative seroma).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMAGARD KNITTED GRAFT
Type of Device
VASCULAR POLYESTER GRAFT
Manufacturer (Section D)
INTERVASCULAR SAS
zi athelia 1
la ciotat cedex, 13705
FR  13705
MDR Report Key7357337
MDR Text Key103028380
Report Number1640201-2018-00012
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00384401015109
UDI-Public00384401015109
Combination Product (y/n)N
PMA/PMN Number
K964625
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 09/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model NumberHGKAX0808
Device Catalogue NumberHGKAX0808
Device Lot Number17E25
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received08/31/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient Weight100
-
-